Home/Filings/4/0001127602-25-020653
4//SEC Filing

Hernandez John 4

Accession 0001127602-25-020653

CIK 0000943819other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 1:10 PM ET

Size

8.3 KB

Accession

0001127602-25-020653

Insider Transaction Report

Form 4
Period: 2025-08-18
Transactions
  • Exercise/Conversion

    ResMed Common Stock

    2025-08-18$148.90/sh+2,575$383,4186,620 total
  • Sale

    ResMed Common Stock

    2025-08-18$287.10/sh2,575$739,2894,045 total
  • Exercise/Conversion

    ResMed Common Stock Options

    2025-08-182,5750 total
    Exercise: $148.90From: 2024-11-11Exp: 2030-11-16ResMed Common Stock (2,575 underlying)
Footnotes (2)
  • [F1]This transaction was executed in multiple trades at prices ranging from $286.90 - $287.24. The price reported above reflects the weighted average sale price.
  • [F2]Represents the date options become exercisable. Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date.

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1
  • filerCIK 0001890555

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 1:10 PM ET
Size
8.3 KB